Three new weight-loss drugs: Will they work?
Here’s the good news: Three new weight-loss drugs are on the horizon that could help overweight and obese people shed pounds. A Food and Drug Administration panel is meeting on Thursday to discuss one of the drugs, Qnexa, and the panel is scheduled to consider two more drugs, lorcaserin and Contrave, in the coming months.
Weight-loss drug faces US test
WASHINGTON – THE first potential US prescription weight-loss pill in more than a decade could move closer to market on Thursday if it can overcome safety hurdles that have plagued diet drugs for years and led to tepid sales despite the growing number of obese Americans. Vivus Inc is seeking Food and Drug Administration support to sell its drug, Qnexa, to adults to use once-a-day along with …
Vivus’ weight-loss drug faces key U.S. test
The first potential U.S. prescription weight-loss pill in more than a decade could move closer to market on Thursday if it can overcome safety hurdles that have plagued diet drugs for years and led to tepid sales despite the growing number of obese Americans. Food and Drug Administration – Obesity – Qnexa – Health – United States
